Cargando…

Pathogenesis of Human Immunodeficiency Virus-Mycobacterium tuberculosis Co-Infection

Given that infection with Mycobacterium tuberculosis (Mtb) is the leading cause of death amongst individuals living with HIV, understanding the complex mechanisms by which Mtb exacerbates HIV infection may lead to improved treatment options or adjuvant therapies. While it is well-understood how HIV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Kevin, Nguyen, James, Blair, Lillie, Banjanin, Marina, Grewal, Bunraj, Bowman, Shane, Boyd, Hailey, Gerstner, Grant, Cho, Hyun Jun, Panfilov, David, Tam, Cho Ki, Aguilar, Delaney, Venketaraman, Vishwanath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694603/ https://www.ncbi.nlm.nih.gov/pubmed/33172001 http://dx.doi.org/10.3390/jcm9113575

Ejemplares similares

Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection
por: Guilford, Timothy, et al.
Publicado: (2010)

Mycobacterium tuberculosis
por: Venketaraman, Vishwanath, et al.
Publicado: (2015)

Editorial: Causes for Increased Susceptibility to Mycobacterium tuberculosis – A Close View of the Immune System
por: Venketaraman, Vishwanath
Publicado: (2015)

General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus
por: To, Kimberly, et al.
Publicado: (2020)

Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection
por: Warren, Eric, et al.
Publicado: (2017)

Neutrophils in Mycobacterium tuberculosis
por: Alcantara, Cheldon Ann, et al.
Publicado: (2023)

A Role of Intracellular Toll-Like Receptors (3, 7, and 9) in Response to Mycobacterium tuberculosis and Co-Infection with HIV
por: Nguyen, Huy, et al.
Publicado: (2020)

Mycobacterium tuberculosis: Implications of Ageing on Infection and Maintaining Protection in the Elderly
por: Bonavida, Victor, et al.
Publicado: (2022)

Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in Mycobacterium tuberculosis Infection
por: Cerni, Stephen, et al.
Publicado: (2019)

Review of the Effectiveness of Various Adjuvant Therapies in Treating Mycobacterium tuberculosis
por: Amin, Arman, et al.
Publicado: (2021)

Pathogenesis, Diagnostic Challenges, and Risk Factors of Pott’s Disease
por: Glassman, Ira, et al.
Publicado: (2023)

Role of B Cells in Mycobacterium Tuberculosis Infection
por: Stewart, Paul, et al.
Publicado: (2023)

Analysis of Tuberculosis Meningitis Pathogenesis, Diagnosis, and Treatment
por: Arshad, Aysha, et al.
Publicado: (2020)

Protective Efficacy of BCG Vaccine against Mycobacterium leprae and Non-Tuberculous Mycobacterial Infections
por: Orujyan, Davit, et al.
Publicado: (2022)

Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially Mycobacterium tuberculosis
por: Ferlita, Steve, et al.
Publicado: (2019)

Recent Advances in Mycobacterial Research
por: Venketaraman, Vishwanath
Publicado: (2020)

Role of NF-κB during Mycobacterium tuberculosis Infection
por: Poladian, Nicole, et al.
Publicado: (2023)

Understanding the Relationship between Glutathione, TGF-β, and Vitamin D in Combating Mycobacterium tuberculosis Infections
por: Singh, Mohkam, et al.
Publicado: (2020)

Pathogenicity of Type I Interferons in Mycobacterium tuberculosis
por: Mundra, Akaash, et al.
Publicado: (2023)

The Role of Obesity in Breast Cancer Pathogenesis
por: Glassman, Ira, et al.
Publicado: (2023)

Role of Interferons in Mycobacterium tuberculosis Infection
por: Shanmuganathan, Gaithrri, et al.
Publicado: (2022)

Effects of Everolimus in Modulating the Host Immune Responses against Mycobacterium tuberculosis Infection
por: Raien, Anmol, et al.
Publicado: (2023)

Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione
por: Allen, Michael, et al.
Publicado: (2015)

Flavonoid Mixture Inhibits Mycobacterium tuberculosis Survival and Infectivity
por: Cao, Ruoqiong, et al.
Publicado: (2019)

Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects
por: Venketaraman, Vishwanath, et al.
Publicado: (2006)

SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations
por: Rangchaikul, Patrida, et al.
Publicado: (2021)

Glutathione and Adaptive Immune Responses against Mycobacterium tuberculosis Infection in Healthy and HIV Infected Individuals
por: Guerra, Carlos, et al.
Publicado: (2011)

Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection
por: Islamoglu, Hicret, et al.
Publicado: (2018)

Analysis of COVID-19 on Diagnosis, Vaccine, Treatment, and Pathogenesis with Clinical Scenarios
por: Tellez, Daniel, et al.
Publicado: (2021)

Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

An Elucidation of Neutrophil Functions against Mycobacterium tuberculosis Infection
por: Morris, Devin, et al.
Publicado: (2013)

Editorial: Immunometabolic mechanisms underlying the severity of COVID-19
por: Kzhyshkowska, Julia, et al.
Publicado: (2022)

Editorial: Community series in immunometabolic mechanisms underlying the severity of COVID-19, volume II
por: Kzhyshkowska, Julia, et al.
Publicado: (2023)

Additive Effects of Cyclic Peptide [R4W4] When Added Alongside Azithromycin and Rifampicin against Mycobacterium avium Infection
por: Kelley, Melissa, et al.
Publicado: (2023)

Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis
por: Teskey, Garrett, et al.
Publicado: (2018)

Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering The Immune Responses Against Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19
por: Yegiazaryan, Aram, et al.
Publicado: (2022)

Cutaneous Manifestations of Mycobacterium tuberculosis: A Literature Review
por: Nguyen, Kevin H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tmenna4h1fn8alkcspga58i453